TARDBP and amyotrophic lateral sclerosis: In the case of ALS, non-pathogenic, intermediate-length ataxin-2 forms a complex with TDP-43 that causes mislocalization of ataxin-2 in a manner that is significantly associated with disease (Nonhoff et al., 2007; Inagaki et al., 2021).